Conduit Pharmaceuticals (US:CDT) — Company Overview, News & Financial Data
Conduit Pharmaceuticals is a clinical-stage biopharmaceutical firm developing drugs for unmet medical needs in San Diego.
CDTConduit Pharmaceuticals
Company profile
Conduit Pharmaceuticals
Conduit Pharmaceuticals (NASDAQ:CDT) is a clinical-stage biopharmaceutical company focusing on developing drugs for unmet medical needs. They prioritize assets overlooked by larger companies. Their pipeline includes a drug in Phase II for autoimmune diseases and a potential treatment for male infertility. The company is headquartered in San Diego, California.
Snapshot
Public USOwnership
2019Year founded
4Employees
San Diego, United StatesHead office
Loading Map...
Global footprint
Operations
All Locations
United States
Products and/or services of Conduit Pharmaceuticals
- Drug Development: Conduit identifies promising drug candidates with the potential to address unmet medical needs.
- Clinical Trials: They design and conduct clinical trials to test the safety and efficacy of their drug candidates.
- Partnerships: Conduit may collaborate with other pharmaceutical companies to develop and commercialize their drugs.
- Autoimmune Disease Treatments: Their current pipeline prioritizes drugs for autoimmune diseases like uveitis and Hashimoto's Thyroiditis.
- Male Infertility Treatment: They're also exploring treatments for idiopathic male infertility.
- Licensing: Conduit might license their developed drugs to other companies for further development or commercialization.
Conduit Pharmaceuticals executive team
- Dr. Andrew ReganFounder, CEO & Director
- Mr. James BlighCo-Founder, CFO & Director
- Dr. Joanne M. HollandChief Scientific Officer